Levothyroxine Sodium Tablet
Product Images NDC 68071-3730

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68071-3730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)

Image-1 (51ff81f2 92d7 4d05 92e4 04272f9447da 01)
Chemical structure of Levothyroxine Sodium showing iodine-substituted phenyl rings, hydroxyl group, ether linkage, and sodium salt of the amino acid moiety with variable hydration (xH2O).*
FDA Label Image

Pdp (68071 3730 9)

Pdp (68071 3730 9)
NuCare Pharmaceuticals, Inc. label for Levothyroxine Sodium 150 mcg tablets. The label indicates a package of 90 tablets, round and blue with scoring and specific markings. It includes the NDC 68071-3730-9, lot and expiration placeholders, manufacturer details, and warnings to keep out of reach of children and store at controlled temperature 68-77°F.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.